63
1
0
Like?
Please wait...
About This Project
We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.
Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

Browse Other Projects on Experiment
Related Projects
Working towards a low-cost ostomy bag that doesn't leak
Ostomy bags are a daily medical necessity for 15 million people globally. However, these bags often delaminate...
How do cataracts form and how can they be prevented?
Cataract is the leading cause of blindness worldwide. The lens in our eye is important for focusing images...
Molecular target-based focused screen for Chagas' disease therapeutic drug discovery
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6...